Tufts Medical Center has appointed Saul N. Weingart, MD, PhD, of Newton, Massachusetts as its next Chief Medical Officer. Dr. Weingart is currently serving as Vice President for Quality Improvement and Patient Safety at Dana-Farber Cancer Institute in Boston. He is a nationally renowned leader in the movement to improve hospital quality.
Dr. Weingart succeeds Michael Wagner, MD, who was named Chief Executive Officer of the Tufts Medical Center Physicians Organization last year, and has continued to fill the role of Chief Medical Officer during the search for his successor.
Quality, Innovation, Patient Safety
“I know Dr. Weingart will do an incredible job continuing initiatives already launched at Tufts Medical Center and establishing new projects and goals for our future,” Dr. Wagner said. He added “Saul Weingart is a name that is synonymous with quality, innovation, and patient safety. I am extremely pleased that his name now will also be associated with Tufts Medical Center.”
“I look forward to working with Tufts’ extraordinary staff to continue the organization’s rich tradition of superb patient care, research, and education,” said Dr. Weingart.
While at Dana Farber, Dr. Weingart led a series of quality and safety initiatives that had significant impact on the organization. He implemented infection control enhancements, including universal influenza vaccinations for staff - improving compliance from 58% to 100% in 4 years.
Dr. Weingart earned his his PhD degree from Harvard, and his MD degree from the University of Rochester. At Dana-Farber, he has continued an active clinical practice in internal medicine and the care of adult survivors of pediatric cancers. He will also see patients with Tufts Medical Center’s General Medical Associates.
Dr. Weingart is nationally recognized for his efforts in patient safety. He recently received the John Eisenberg Award for Patient Safety and Quality, one of the highest quality awards in the country, from the National Quality Forum and The Joint Commission. ■
